Literature DB >> 8603388

Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk.

H Garewal1, H Bernstein, C Bernstein, R Sampliner, C Payne.   

Abstract

Dietary factors, including bile acids, are important in the causation of colorectal cancer (CRC). We have previously shown that in vitro exposure of colorectal mucosal biopsies to low concentrations of bile acids produces apoptosis selectively in goblet cells. Apoptosis is an important mechanism for clearing DNA-damaged cells. Inhibition of apoptosis would result in increasing accumulation of DNA-damaged cells, resulting in increased cancer risk. We compared the percentage of apoptosis induced by bile acids in mucosal biopsies from CRC patients with that of noncancer subjects. Mucosal biopsies from 15 to 20 cm from the anal verge were incubated in 1 mM sodium deoxycholate, and the percentage of goblet cells undergoing apoptosis was quantitated. Seven patients with a history of CRC within the previous 5 years were compared with 18 noncancer subjects [4 neoplasia free and 14 with small (< or = 9 mm) polyps only]. The CRC patients had a significantly lower percentage of apoptosis than noncancer subjects; the mean for CRC was 10.7% (range, 0.9-26%) and for noncancer subjects was 55.9% (range, 20.3-71%; P < or = 0.001). Two other noncancer patients had very high-risk lesions, i.e., large villous adenomas and multiple large polyps during several colonoscopies over the previous 6 years. Their percentage of apoptosis was in the cancer range, i.e., 6.2 and 10.7%. Reduced apoptotic ability may imply increased cancer risk. By applying a quantitative bile acid-induced apoptosis assay to colorectal mucosal biopsies, the percentage of apoptosis was found to be significantly reduced in CRC patients. This assay may prove to be a useful intermediate biological marker for identifying subjects at increased risk of cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603388

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Energetics by NMR: site-specific binding in a positively cooperative system.

Authors:  Gregory P Tochtrop; Klaus Richter; Changguo Tang; James J Toner; Douglas F Covey; David P Cistola
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 2.  Barrett's esophagus: environmental influences in the progression of dysplasia.

Authors:  Ralph A Boulton; Bernhard Usselmann; Imtiyaz Mohammed; Janusz Jankowski
Journal:  World J Surg       Date:  2003-07-28       Impact factor: 3.352

3.  Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue.

Authors:  Harinder Garewal; Lois Ramsey; Ronnie Fass; Nancy K Hart; Claire M Payne; Harris Bernstein; Carol Bernstein
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

4.  Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas.

Authors:  M Anti; A Armuzzi; S Morini; E Iascone; G Pignataro; C Coco; R Lorenzetti; M Paolucci; M Covino; A Gasbarrini; F Vecchio; G Gasbarrini
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 5.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

6.  Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats.

Authors:  Michele Barone; Eugenio Maiorano; Roberta Ladisa; Antonia Pece; Pasquale Berloco; Mario Strazzabosco; Maria Lucia Caruso; Anna Maria Valentini; Enzo Ierardi; Alfredo Di Leo; Antonio Francavilla
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

7.  Analyzing the regulation of metabolic pathways in human breast cancer.

Authors:  Gunnar Schramm; Eva-Maria Surmann; Stefan Wiesberg; Marcus Oswald; Gerhard Reinelt; Roland Eils; Rainer König
Journal:  BMC Med Genomics       Date:  2010-09-10       Impact factor: 3.063

Review 8.  Experimental evidence for mutagenic potential of duodenogastric juice on Barrett's esophagus.

Authors:  Joerg Theisen; Jeffrey H Peters; Hubert J Stein
Journal:  World J Surg       Date:  2003-07-17       Impact factor: 3.352

Review 9.  Field defects in progression to gastrointestinal tract cancers.

Authors:  Carol Bernstein; Harris Bernstein; Claire M Payne; Katerina Dvorak; Harinder Garewal
Journal:  Cancer Lett       Date:  2007-12-31       Impact factor: 8.679

10.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.